Development of an Aid to Melanoma Detection Using Artificial Intelligence Algorithms Based on Images From the VECTRA 3D System.

ConditionNaevi
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorAssistance Publique Hopitaux De Marseille

About this trial

The background to this research is that frequent medical screening of the general population for melanoma is not feasible. The real challenge of this project is to develop an automatic process for detecting any potential melanoma. To this end, the project aims to design an algorithm to build a novel diagnostic aid that makes use of the similarity and disparity of pigmented lesions in the same patient. To achieve this, we need to obtain and structure a large database of images grouping all pigmented lesions per patient according to their similarities as perceived by dermatologists.

Eligibility criteria

Qualifiers

Male or female aged 18 and over

Patient with more than 15 nevi (moles) of various phototypes (I to III)

Patient who has received information about the study and has not expressed any opposition

Patient who is a beneficiary or entitled person under a social security scheme

Disqualifiers

Patients with phototype V

Patients with chronic inflammatory skin diseases

Claustrophobic patients

Patients who are bedridden or handicapped

Trial design

Treatments tested in this trial

  • Scanner of the whole body using the VECTRA 3D

Treatment groups

1,000 Participants
are divided into 1 treatment group